Inhibition of the intrinsic factor X activating complex by protein S: evidence for a specific binding of protein S to factor VIII.

Abstract:

:Protein S is a vitamin K-dependent nonenzymatic anticoagulant protein that acts as a cofactor to activated protein C. Recently it was shown that protein S inhibits the prothrombinase reaction independent of activated protein C. In this study, we show that protein S can also inhibit the intrinsic factor X activation via a specific interaction with factor VIII. In the presence of endothelial cells, the intrinsic activation of factor X was inhibited by protein S with an IC50 value of 0.28 +/- 0.04 mumol/L corresponding to the plasma concentration of protein S. This inhibitory effect was even more pronounced when the intrinsic factor X activation was studied in the presence of activated platelets (IC50 = 0.15 +/- 0.02 mumol/L). When a nonlimiting concentration of phospholipid vesicles was used, the plasma concentration of protein S (300 nmol/L) inhibited the intrinsic factor X activation by 40%. Thrombin-cleaved protein S inhibited the endothelial cell-mediated factor X activation with an IC50 similar to that of native protein S (0.26 +/- 0.02 mumol/L). Protein S in complex with C4b-binding protein inhibited the endothelial cell-mediated factor X activation more potently than protein S alone (IC50 = 0.19 +/- 0.03 mumol/L). Using thrombin activated factor VIII, IC50 values of 0.53 +/- 0.09 mumol/L and 0.46 +/- 0.10 mumol/L were found for native protein S and thrombin-cleaved protein S, respectively. The possible interactions of protein S with factor IXa, phospholipids, and factor VIII were investigated. The enzymatic activity of factor IXa was not affected by protein S, and interaction of protein S with the phospholipid surface could not fully explain the inhibitory effect of protein S on the factor X activation. Using a solid-phase binding assay, we showed a specific, saturable, and reversible binding of protein S to factor VIII with a high affinity. The concentration of protein S where half-maximal binding was reached (B1/2max) was 0.41 +/- 0.06 mumol/L. A similar affinity was found for the interaction of thrombin-cleaved protein S with factor VIII (B1/2max = 0.40 +/- 0.04 mumol/L). The affinity of the complex protein S with C4B-binding protein appeared to be five times higher (B1/2max = 0.07 +/- 0.03 mumol/L). Because the affinities of the interaction of the different forms of protein S with factor VIII correspond to the IC50 values observed for the intrinsic factor X activating complex, the interaction of protein S with factor VIII may explain the inhibitory effect of protein S on the intrinsic factor X activating complex.(ABSTRACT TRUNCATED AT 400 WORDS)

journal_name

Blood

journal_title

Blood

authors

Koppelman SJ,Hackeng TM,Sixma JJ,Bouma BN

subject

Has Abstract

pub_date

1995-08-01 00:00:00

pages

1062-71

issue

3

eissn

0006-4971

issn

1528-0020

journal_volume

86

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Impairment of lymphopoiesis and myelopoiesis in mice reconstituted with bone marrow-hematopoietic progenitor cells expressing SDF-1-intrakine.

    abstract::Both SDF-1 and CXCR4 disruption are lethal to mice at the embryonic stage and cause abnormalities in B lymphopoiesis, myelopoiesis, cardiogenesis, vasculogenesis, and cerebellar development. To investigate the role of SDF-1 and CXCR4 in hematopoiesis during the adult stage, mice reconstituted with bone marrow-derived ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Onai N,Zhang Yy,Yoneyama H,Kitamura T,Ishikawa S,Matsushima K

    更新日期:2000-09-15 00:00:00

  • Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children's Oncology Group.

    abstract::AALL07P2 evaluated whether substitution of Erwinia asparaginase 25000 IU/m(2) for 6 doses given intramuscularly Monday/Wednesday/Friday (M/W/F) to children and young adults with acute lymphoblastic leukemia and clinical allergy to pegaspargase would provide a 48-hour nadir serum asparaginase activity (NSAA) ≥ 0.10 IU/...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood-2013-01-480822

    authors: Salzer WL,Asselin B,Supko JG,Devidas M,Kaiser NA,Plourde P,Winick NJ,Reaman GH,Raetz E,Carroll WL,Hunger SP

    更新日期:2013-07-25 00:00:00

  • Rapid purification and characterization of human platelet glycoprotein V: the amino acid sequence contains leucine-rich repetitive modules as in glycoprotein Ib.

    abstract::Glycoprotein V (GPV) is a membrane-associated, 82 Kd platelet glycoprotein that is hydrolyzed during thrombin activation to yield 69 Kd fragment. We have developed a rapid and simple method for isolation of the protein from platelet extracts using a combination of gel permeation, anion-exchange, and lectin affinity ch...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Shimomura T,Fujimura K,Maehama S,Takemoto M,Oda K,Fujimoto T,Oyama R,Suzuki M,Ichihara-Tanaka K,Titani K

    更新日期:1990-06-15 00:00:00

  • Evidence for an upper affinity threshold for anti-IgM-induced apoptosis in a human B-cell lymphoma.

    abstract::The influence of ligand:receptor affinity on B-cell antigen receptor (BCR)-induced apoptosis in the IgM+ Burkitt lymphoma line, Ramos, was evaluated with a group of affinity-diverse murine monoclonal antibodies (MoAbs) specific for human B-cell IgM. The studies showed not only a minimal affinity threshold for the indu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mongini PK,Liu Q,Vilensky MA,Highet PF,Inman JK

    更新日期:1998-11-15 00:00:00

  • Conformational changes in the D' domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment.

    abstract::We report 2 new mutations identified in 3 patients and characterized by the markedly decreased affinity of von Willebrand factor (vWF) for factor VIII (FVIII). Patients 2 and 3, who have a typical type 2N phenotype, were found to be compound heterozygous for Arg91Gln and Cys25Tyr or Cys95Phe, respectively. Patient 1, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Jorieux S,Fressinaud E,Goudemand J,Gaucher C,Meyer D,Mazurier C

    更新日期:2000-05-15 00:00:00

  • Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.

    abstract::The antibody-mediated delivery of therapeutic agents to sites of angiogenesis is an attractive strategy for anticancer therapy, but is largely unexplored in hematologic malignancies. In the present study, we show that the extra domain B (EDB) of fibronectin, a marker of angiogenesis, is expressed in B-cell non-Hodgkin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-160747

    authors: Schliemann C,Palumbo A,Zuberbühler K,Villa A,Kaspar M,Trachsel E,Klapper W,Menssen HD,Neri D

    更新日期:2009-03-05 00:00:00

  • Induction of fetal hemoglobin through enhanced translation efficiency of γ-globin mRNA.

    abstract::Fetal hemoglobin (HbF) induction can ameliorate the clinical severity of sickle cell disease and β-thalassemia. We previously reported that activation of the eukaryotic initiation factor 2α (eIF2α) stress pathway increased HbF through a posttranscriptional mechanism. In this study, we explored the underlying means by ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-03-564302

    authors: Hahn CK,Lowrey CH

    更新日期:2014-10-23 00:00:00

  • Dominant-negative C/ebpα and polycomb group protein Bmi1 extend short-lived hematopoietic stem/progenitor cell life span and induce lethal dyserythropoiesis.

    abstract::The primitive hematopoietic stem/progenitor cells (HSPCs) during embryonic hematopoiesis are thought to be short-lived (SL) with limited self-renewal potential. The fate and consequence of these short-lived HSPCs, once reprogrammed into "long-lived" in a living animal body, remain unknown. Here we show that targeted e...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-12-327908

    authors: Zhou T,Wang L,Zhu KY,Dong M,Xu PF,Chen Y,Chen SJ,Chen Z,Deng M,Liu TX

    更新日期:2011-10-06 00:00:00

  • Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin.

    abstract::Heparin-induced thrombocytopenia (HIT) is caused by platelet-activating IgG antibodies that recognize platelet factor 4 (PF4) bound to heparin. Immunogenicity of heparins differs in that unfractionated heparin (UFH) induces more anti-PF4/heparin antibodies than low-molecular-weight heparin (LMWH) and UFH also causes m...

    journal_title:Blood

    pub_type: 杂志文章,随机对照试验

    doi:10.1182/blood-2005-05-1938

    authors: Warkentin TE,Cook RJ,Marder VJ,Sheppard JA,Moore JC,Eriksson BI,Greinacher A,Kelton JG

    更新日期:2005-12-01 00:00:00

  • Transcription of the activating receptor NKG2D in natural killer cells is regulated by STAT3 tyrosine phosphorylation.

    abstract::Signal transducer and activator of transcription 3 (STAT3) is considered a negative regulator of inflammation, as inhibition of STAT3 signaling enhances antitumor immunity. However, STAT3 activation is a key oncogenic pathway in natural killer (NK)-lineage large granular lymphomas, and we recently reported enhanced pr...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-05-499707

    authors: Zhu S,Phatarpekar PV,Denman CJ,Senyukov VV,Somanchi SS,Nguyen-Jackson HT,Mace EM,Freeman AF,Watowich SS,Orange JS,Holland SM,Lee DA

    更新日期:2014-07-17 00:00:00

  • Activated protein C ameliorates chronic graft-versus-host disease by PAR1-dependent biased cell signaling on T cells.

    abstract::Soluble thrombomodulin plasma concentrations are elevated in steroid-resistant graft-versus-host disease (GVHD), implying endothelial hypofunctioning for thrombomodulin-dependent generation of activated protein C's (APC) anticoagulant, anti-inflammatory, and antiapoptotic functions. Recombinant thrombomodulin or APC a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001259

    authors: Sinha RK,Flynn R,Zaiken M,Paz K,Gavin AL,Nemazee D,Fernández JA,Xu X,Griffin JH,Blazar BR

    更新日期:2019-08-29 00:00:00

  • Use of alpha interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after allogeneic bone marrow transplantation.

    abstract::Eighteen patients with relapse of chronic myelogenous leukemia (CML) after allogeneic bone marrow transplantation (BMT) were treated with recombinant human alpha 2a interferon (IFN). Relapse was defined as greater than 90% metaphases containing the Philadelphia chromosome (Ph) and hematologic abnormalities consistent ...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:

    authors: Higano CS,Raskind WH,Singer JW

    更新日期:1992-09-15 00:00:00

  • Tisagenlecleucel CAR T-cell therapy in secondary CNS lymphoma.

    abstract::Chimeric antigen receptor (CAR) T cells targeting CD19 have emerged as a leading engineered T-cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma. The phase 1/2 clinical trials that led to US Food and Drug Administration approval excluded patients with central nervous system (CNS) involvement, due to stri...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019001694

    authors: Frigault MJ,Dietrich J,Martinez-Lage M,Leick M,Choi BD,DeFilipp Z,Chen YB,Abramson J,Crombie J,Armand P,Nayak L,Panzini C,Riley LS,Gallagher K,Maus MV

    更新日期:2019-09-12 00:00:00

  • Sox4 cooperates with Evi1 in AKXD-23 myeloid tumors via transactivation of proviral LTR.

    abstract::Myeloid leukemias in AKXD23 mice contain proviral insertions at Evi1, resulting in transcriptional activation. Although Evi1 is clearly involved in leukemia, gene transfer studies in mice with Evi1 fail to cause leukemia, arguing that cooperating events are necessary. We reanalyzed AKXD-23 tumors for cooperating provi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1626

    authors: Boyd KE,Xiao YY,Fan K,Poholek A,Copeland NG,Jenkins NA,Perkins AS

    更新日期:2006-01-15 00:00:00

  • Safety of anticoagulants in children with arterial ischemic stroke.

    abstract::Pediatric arterial ischemic stroke (AIS) is increasingly diagnosed and carries significant risks of recurrence, morbidity, and mortality. Anticoagulant therapy (ACT) is commonly prescribed in childhood AIS. Hemorrhagic complication rates in pediatric stroke are unknown, and adult safety data are of limited applicabili...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-06-361535

    authors: Schechter T,Kirton A,Laughlin S,Pontigon AM,Finkelstein Y,MacGregor D,Chan A,deVeber G,Brandão LR

    更新日期:2012-01-26 00:00:00

  • Role of GM-CSF signaling in cell-based tumor immunization.

    abstract::Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a potent adjuvant in cancer vaccination; however, the specific role of endogenous GM-CSF remains unknown. We performed cell-based vaccination in 2 tumor models. First, we vaccinated C57BL/6 mice lacking either GM-CSF, IL-5, or beta-common chain (betac), a re...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-161075

    authors: Zarei S,Schwenter F,Luy P,Aurrand-Lions M,Morel P,Kopf M,Dranoff G,Mach N

    更新日期:2009-06-25 00:00:00

  • Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms.

    abstract::Essential thrombocythemia (ET) and primary myelofibrosis (PMF) are chronic diseases characterized by clonal hematopoiesis and hyperproliferation of terminally differentiated myeloid cells. The disease is driven by somatic mutations in exon 9 of CALR or exon 10 of MPL or JAK2-V617F in >90% of the cases, whereas the rem...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-07-661835

    authors: Milosevic Feenstra JD,Nivarthi H,Gisslinger H,Leroy E,Rumi E,Chachoua I,Bagienski K,Kubesova B,Pietra D,Gisslinger B,Milanesi C,Jäger R,Chen D,Berg T,Schalling M,Schuster M,Bock C,Constantinescu SN,Cazzola M,Kralovi

    更新日期:2016-01-21 00:00:00

  • Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs.

    abstract::Cyclophosphamide (CTX), a commonly used chemotherapeutic agent can enhance immune responses. The ability of CTX to promote the proliferation of effector T cells and abrogate the function of regulatory T cells (Tregs) has been described. In this study, we examined the effects of CTX treatment on dendritic cell (DC) sub...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-11-251231

    authors: Nakahara T,Uchi H,Lesokhin AM,Avogadri F,Rizzuto GA,Hirschhorn-Cymerman D,Panageas KS,Merghoub T,Wolchok JD,Houghton AN

    更新日期:2010-06-03 00:00:00

  • A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction.

    abstract::Adult T-cell leukemia (ATL) is neoplasm of the mature helper T lymphocytes and human T-cell lymphotropic virus type-I (HTLV-I) has been shown to be causative virus of ATL. Because HTLV-I integrates its provirus randomly into host chromosomal DNA, monoclonal integration of HTLV-I provirus indicates the clonal prolifera...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Takemoto S,Matsuoka M,Yamaguchi K,Takatsuki K

    更新日期:1994-11-01 00:00:00

  • Activation of p38 MAP kinase pathway by erythropoietin and interleukin-3.

    abstract::Activation of p38 MAP kinase (p38) as well as JNK/SAPK has been described as being induced by a variety of environmental stresses such as osmotic shock, ultraviolet radiation, and heat shock, or the proinflammatory cytokines tumor necrosis factor-alpha and interleukin-1 (IL-1). We found that the hematopoietic cytokine...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Nagata Y,Moriguchi T,Nishida E,Todokoro K

    更新日期:1997-08-01 00:00:00

  • Reduced retinoic acid-sensitivities of nuclear receptor corepressor binding to PML- and PLZF-RARalpha underlie molecular pathogenesis and treatment of acute promyelocytic leukemia.

    abstract::Typical acute promyelocytic leukemia (APL) is associated with expression of the PML-RARalpha fusion protein and responsiveness to treatment with all-trans retinoic acid (ATRA). A rare, but recurrent, APL has been described that does not respond to ATRA treatment and is associated with a variant chromosomal translocati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Guidez F,Ivins S,Zhu J,Söderström M,Waxman S,Zelent A

    更新日期:1998-04-15 00:00:00

  • von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.

    abstract::Stroke is a leading cause of death and disability. The only therapy available is recombinant tissue plasminogen activator, but side effects limit its use. Platelets play a crucial role during stroke, and the inflammatory reaction promotes neurodegeneration. von Willebrand factor (VWF), an adhesion molecule for platele...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-213264

    authors: Zhao BQ,Chauhan AK,Canault M,Patten IS,Yang JJ,Dockal M,Scheiflinger F,Wagner DD

    更新日期:2009-10-08 00:00:00

  • Double-negative (CD4- CD8-) T cells from adult T-cell leukemia patients also have poor expression of the T-cell receptor alpha beta/CD3 complex.

    abstract::We present four patients with adult T-cell leukemia (ATL) derived from a novel T-cell subset (CD4-, CD8- [double-negative, DN], T-cell receptor [TCR] alpha beta+). In the ATL cells of these patients, neither gene nor surface expression of CD4 and CD8 antigens was detected. Clinical and laboratory data showed no differ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Suzushima H,Asou N,Nishimura S,Nishikawa K,Wang JX,Okubo T,Naito M,Hattori T,Takatsuki K

    更新日期:1993-02-15 00:00:00

  • The hematopoietic stem cell niche in homeostasis and disease.

    abstract::The bone marrow microenvironment contains a heterogeneous population of stromal cells organized into niches that support hematopoietic stem cells (HSCs) and other lineage-committed hematopoietic progenitors. The stem cell niche generates signals that regulate HSC self-renewal, quiescence, and differentiation. Here, we...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2015-07-533588

    authors: Calvi LM,Link DC

    更新日期:2015-11-26 00:00:00

  • FBXW7 mutations reduce binding of NOTCH1, leading to cleaved NOTCH1 accumulation and target gene activation in CLL.

    abstract::NOTCH1 is mutated in 10% of chronic lymphocytic leukemia (CLL) patients and is associated with poor outcome. However, NOTCH1 activation is identified in approximately one-half of CLL cases even in the absence of NOTCH1 mutations. Hence, there appear to be additional factors responsible for the impairment of NOTCH1 deg...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2018-09-874529

    authors: Close V,Close W,Kugler SJ,Reichenzeller M,Yosifov DY,Bloehdorn J,Pan L,Tausch E,Westhoff MA,Döhner H,Stilgenbauer S,Oswald F,Mertens D

    更新日期:2019-02-21 00:00:00

  • Platelet modulation of polymorphonuclear leukocyte shear induced aggregation.

    abstract::A cone and plate viscometer and Coulter Counter were used to study platelet modulation of polymorphonuclear leukocyte (PMNL) aggregation caused by controlled shear stress. As an index of aggregation, the large-particle percentage (LPP) was calculated. This represents the ratio of aggregated cell count to total cell co...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rhee BG,Hall ER,McIntire LV

    更新日期:1986-01-01 00:00:00

  • Chronic myelodysplastic syndrome (preleukemia) with the Philadelphia chromosome.

    abstract::A patient with severe anemia, reticulocytopenia, and erythroid hyperplasia of the bone marrow developed fatal acute nonlymphocytic leukemia after 3 yr. A Philadelphia chromosome with the typical 9/22 translocation t(9q +;22q-) was identified by banding techniques in a small number of bone marrow cells throughout the p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Roth DG,Richman CM,Rowley JD

    更新日期:1980-08-01 00:00:00

  • Activities of four purified growth factors on highly enriched human hematopoietic progenitor cells.

    abstract::The activities of four purified human growth factors: biosynthetic (recombinant) granulocyte-macrophage colony-stimulating factor (GM-CSF); recombinant erythroid-potentiating activity (EPA); natural and recombinant pluripoietin (Ppo); and natural pluripoietin alpha (Ppo alpha), were compared on the growth of hematopoi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Strife A,Lambek C,Wisniewski D,Gulati S,Gasson JC,Golde DW,Welte K,Gabrilove JL,Clarkson B

    更新日期:1987-05-01 00:00:00

  • CD10/neutral endopeptidase 24.11 is phosphorylated by casein kinase II and coassociates with other phosphoproteins including the lyn src-related kinase.

    abstract::CD10/neutral endopeptidase 24.11 (NEP) regulates peptidemediated proliferation of lymphoid progenitors and certain epithelial cells and is itself regulated by cellular proliferation. To further characterize mechanisms by which cell-surface signaling might regulate CD10/NEP expression, we determined whether CD10/NEP wa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ganju RK,Shpektor RG,Brenner DG,Shipp MA

    更新日期:1996-12-01 00:00:00

  • Interleukin-4 suppresses plasminogen activator inhibitor-2 formation in stimulated human monocytes.

    abstract::Using a specific enzyme-linked immunosorbent assay, plasminogen activator inhibitor-2 (PAI-2) was quantitated in cultures of human monocytes. Lipopolysaccharide (LPS) increased both extracellular and cell-associated PAI-2 levels, as well as PAI-2 mRNA measured by Northern analysis. Both the lymphokine, interleukin-4 (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hamilton JA,Whitty GA,Last K,Royston AK,Hart PH,Burgess DR

    更新日期:1992-07-01 00:00:00